Comparative analysis of Peg-Interferon alpha-2b and Lamivudine in the treatment of chronic hepatitis B patients: Preliminary results

被引:1
|
作者
Koliouskas, D [1 ]
Sidiropoulos, I [1 ]
Masmanidou, M [1 ]
Dokas, S [1 ]
Ziakas, A [1 ]
机构
[1] AHEPA Gen Hosp, Thessaloniki, Greece
关键词
D O I
10.1016/S0168-8278(02)80852-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
851
引用
收藏
页码:237 / 238
页数:2
相关论文
共 50 条
  • [21] The effect of lamivudine and interferon alpha-2b (IFNα) on work productivity in patients with chronic hepatitis B (CHB) infection.
    Chatterton, ML
    Brown, N
    Gray, F
    Miller, DW
    HEPATOLOGY, 1998, 28 (04) : 489A - 489A
  • [22] A placebo-controlled study of lamivudine and interferon alpha-2b in patients with chronic hepatitis B who previously failed interferon therapy
    Schiff, E
    Karavalcin, S
    Grimm, I
    Perrillo, R
    Dienstag, J
    Husa, P
    Schalm, S
    Crowther, L
    Sullivan, M
    Woessner, M
    McPhillips, P
    Brown, N
    HEPATOLOGY, 1998, 28 (04) : 388A - 388A
  • [23] Early hepatitis B viral dynamics and end of treatment virological response (ETVR) in chronic hepatitis B/HBeAg (-) patients receiving pegylated interferon alpha-2b and/or lamivudine
    Vassiliadis, T.
    Sypsa, V.
    Mimidis, K.
    Tassopoulos, N. C.
    Chrysagis, D.
    Ketikoglou, I.
    Raptopoulou, M.
    Haida, C.
    Hatzakis, A.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S192 - S192
  • [24] TREATMENT OF CHRONIC HEPATITIS-C WITH RECOMBINANT INTERFERON ALPHA-2B
    TERRANOVA, R
    LUCA, S
    JOURNAL OF CHEMOTHERAPY, 1992, 4 (05) : 297 - 302
  • [25] Liver histology in chronic hepatitis B patients after 1 year of treatment with pegylated interferon alpha-2b in combination with lamivudine or placebo.
    van Zonneveld, M
    Zondervan, P
    de Man, RA
    Schalm, SW
    Janssen, HLA
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2005, 17 (01) : A13 - A13
  • [26] Ribavirin in combination with alpha-2b interferon for the treatment of chronic hepatitis C
    Hillon, P
    PRESSE MEDICALE, 2001, 30 (07): : 335 - 336
  • [27] Impact of liver steatosis on virological response in elderly Italian patients with chronic hepatitis C treated with peg-interferon alpha-2b plus ribavarin
    Fabris, P
    Floreani, A
    Carlotto, A
    Baldo, V
    Bozzola, L
    Giordani, MT
    Negro, F
    Rassu, M
    Tramarin, A
    de Lalla, F
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (09) : 1173 - 1178
  • [28] Extensive psoriasis induced by pegylated interferon alpha-2b treatment for chronic hepatitis B
    Ketikoglou, I
    Karatapanis, S
    Elefsiniotis, L
    Kafiri, G
    Moulakakis, A
    EUROPEAN JOURNAL OF DERMATOLOGY, 2005, 15 (02) : 107 - 109
  • [29] Interferon Alpha-2b Therapy in Chronic Hepatitis Delta
    Keshvari, Maryam
    Alavian, Seyed Moayed
    Sharafi, Heidar
    Karimi, Gharib
    Fesharaki, Mohammad Gholami
    HEPATITIS MONTHLY, 2014, 14 (03)
  • [30] Pegylated Interferon Alpha-2B for the Management of Patients With Chronic Hepatitis Delta
    Gheorghe, Liana
    Iacab, Speranta
    Simionov, Iulia I.
    Vadan, Roxawa
    Constantinescu, Ileana
    Sporea, Ioan
    Grigotescu, Mircea D.
    GASTROENTEROLOGY, 2011, 140 (05) : S454 - S454